Home > > > > Report Detail

Global Human Rabies Immunoglobulin (IM) Market Research Report 2022 Professional Edition

Publisher Name :
Date: 03-Jan-2022
No. of pages: 125

The global Human Rabies Immunoglobulin (IM) market was valued at 26.76 Million USD in 2021 and will grow with a CAGR of 7.3% from 2021 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient`s passive immunization. The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017. For ERIGs, the dosage is 40 IU per kg body weight subject to a maximum of 3000 IU. For HRIGs, the dosage is 20 IU per kg body weight subject to a maximum of 1500 IU. Human Rabies Immunoglobulin (IM) is widely used for the Category II Exposure and Category III Exposure, the most proportion of Human Rabies Immunoglobulin (IM) is used for Category III Exposure, and the proportion in 2017 is about 82.6%. China is the largest sales place, with a sales market share nearly 61.4% in 2017, because of the population. North America enjoys 4.3% market share.

By Market Verdors:

CSL Behring

Grifols

Sanofi

Sichuan Yuanda Shuyang

CNBG

Kamada

CBPO

Shuanglin Bio

Weiguang Bio

Shanghai RAAS

Bharat Serum

VINS

By Types:

ERIG

HRIG

By Applications:

Category II Exposure

Category III Exposure

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements

Global Human Rabies Immunoglobulin (IM) Market Research Report 2022 Professional Edition

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Rabies Immunoglobulin (IM) Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 ERIG
1.4.3 HRIG
1.5 Market by Application
1.5.1 Global Human Rabies Immunoglobulin (IM) Market Share by Application: 2022-2027
1.5.2 Category II Exposure
1.5.3 Category III Exposure
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Human Rabies Immunoglobulin (IM) Market
1.8.1 Global Human Rabies Immunoglobulin (IM) Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Human Rabies Immunoglobulin (IM) Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Rabies Immunoglobulin (IM) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Rabies Immunoglobulin (IM) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Human Rabies Immunoglobulin (IM) Sales Volume Market Share by Region (2016-2021)
3.2 Global Human Rabies Immunoglobulin (IM) Sales Revenue Market Share by Region (2016-2021)
3.3 North America Human Rabies Immunoglobulin (IM) Sales Volume
3.3.1 North America Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.3.2 North America Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Human Rabies Immunoglobulin (IM) Sales Volume
3.4.1 East Asia Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Human Rabies Immunoglobulin (IM) Sales Volume (2016-2021)
3.5.1 Europe Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Human Rabies Immunoglobulin (IM) Sales Volume (2016-2021)
3.6.1 South Asia Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Volume (2016-2021)
3.7.1 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Human Rabies Immunoglobulin (IM) Sales Volume (2016-2021)
3.8.1 Middle East Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Human Rabies Immunoglobulin (IM) Sales Volume (2016-2021)
3.9.1 Africa Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Human Rabies Immunoglobulin (IM) Sales Volume (2016-2021)
3.10.1 Oceania Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Human Rabies Immunoglobulin (IM) Sales Volume (2016-2021)
3.11.1 South America Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.11.2 South America Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Human Rabies Immunoglobulin (IM) Sales Volume (2016-2021)
3.12.1 Rest of the World Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Human Rabies Immunoglobulin (IM) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Human Rabies Immunoglobulin (IM) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Human Rabies Immunoglobulin (IM) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Human Rabies Immunoglobulin (IM) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Human Rabies Immunoglobulin (IM) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Human Rabies Immunoglobulin (IM) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Human Rabies Immunoglobulin (IM) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Human Rabies Immunoglobulin (IM) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Human Rabies Immunoglobulin (IM) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Human Rabies Immunoglobulin (IM) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Human Rabies Immunoglobulin (IM) Sales Volume Market Share by Type (2016-2021)
14.2 Global Human Rabies Immunoglobulin (IM) Sales Revenue Market Share by Type (2016-2021)
14.3 Global Human Rabies Immunoglobulin (IM) Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Human Rabies Immunoglobulin (IM) Consumption Volume by Application (2016-2021)
15.2 Global Human Rabies Immunoglobulin (IM) Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Human Rabies Immunoglobulin (IM) Business
16.1 CSL Behring
16.1.1 CSL Behring Company Profile
16.1.2 CSL Behring Human Rabies Immunoglobulin (IM) Product Specification
16.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Grifols
16.2.1 Grifols Company Profile
16.2.2 Grifols Human Rabies Immunoglobulin (IM) Product Specification
16.2.3 Grifols Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Sanofi
16.3.1 Sanofi Company Profile
16.3.2 Sanofi Human Rabies Immunoglobulin (IM) Product Specification
16.3.3 Sanofi Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Sichuan Yuanda Shuyang
16.4.1 Sichuan Yuanda Shuyang Company Profile
16.4.2 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Specification
16.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 CNBG
16.5.1 CNBG Company Profile
16.5.2 CNBG Human Rabies Immunoglobulin (IM) Product Specification
16.5.3 CNBG Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Kamada
16.6.1 Kamada Company Profile
16.6.2 Kamada Human Rabies Immunoglobulin (IM) Product Specification
16.6.3 Kamada Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 CBPO
16.7.1 CBPO Company Profile
16.7.2 CBPO Human Rabies Immunoglobulin (IM) Product Specification
16.7.3 CBPO Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Shuanglin Bio
16.8.1 Shuanglin Bio Company Profile
16.8.2 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Specification
16.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Weiguang Bio
16.9.1 Weiguang Bio Company Profile
16.9.2 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Specification
16.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Shanghai RAAS
16.10.1 Shanghai RAAS Company Profile
16.10.2 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Specification
16.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Bharat Serum
16.11.1 Bharat Serum Company Profile
16.11.2 Bharat Serum Human Rabies Immunoglobulin (IM) Product Specification
16.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 VINS
16.12.1 VINS Company Profile
16.12.2 VINS Human Rabies Immunoglobulin (IM) Product Specification
16.12.3 VINS Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Human Rabies Immunoglobulin (IM) Manufacturing Cost Analysis
17.1 Human Rabies Immunoglobulin (IM) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
17.4 Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Human Rabies Immunoglobulin (IM) Distributors List
18.3 Human Rabies Immunoglobulin (IM) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Human Rabies Immunoglobulin (IM) (2022-2027)
20.2 Global Forecasted Revenue of Human Rabies Immunoglobulin (IM) (2022-2027)
20.3 Global Forecasted Price of Human Rabies Immunoglobulin (IM) (2016-2027)
20.4 Global Forecasted Production of Human Rabies Immunoglobulin (IM) by Region (2022-2027)
20.4.1 North America Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.4.3 Europe Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.4.7 Africa Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.4.9 South America Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Human Rabies Immunoglobulin (IM) Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
21.2 East Asia Market Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
21.3 Europe Market Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Countriy
21.4 South Asia Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
21.5 Southeast Asia Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
21.6 Middle East Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
21.7 Africa Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
21.8 Oceania Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
21.9 South America Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
21.10 Rest of the world Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

List of Tables and Figures

Key Players Covered: Ranking by Human Rabies Immunoglobulin (IM) Revenue (US$ Million) 2016-2021
Global Human Rabies Immunoglobulin (IM) Market Size by Type (US$ Million): 2022-2027
Global Human Rabies Immunoglobulin (IM) Market Size by Application (US$ Million): 2022-2027
Global Human Rabies Immunoglobulin (IM) Production Capacity by Manufacturers
Global Human Rabies Immunoglobulin (IM) Production by Manufacturers (2016-2021)
Global Human Rabies Immunoglobulin (IM) Production Market Share by Manufacturers (2016-2021)
Global Human Rabies Immunoglobulin (IM) Revenue by Manufacturers (2016-2021)
Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2016-2021)
Global Market Human Rabies Immunoglobulin (IM) Average Price of Key Manufacturers (2016-2021)
Manufacturers Human Rabies Immunoglobulin (IM) Production Sites and Area Served
Manufacturers Human Rabies Immunoglobulin (IM) Product Type
Global Human Rabies Immunoglobulin (IM) Sales Volume by Region (2016-2021)
Global Human Rabies Immunoglobulin (IM) Sales Volume Market Share by Region (2016-2021)
Global Human Rabies Immunoglobulin (IM) Sales Revenue by Region (2016-2021)
Global Human Rabies Immunoglobulin (IM) Sales Revenue Market Share by Region (2016-2021)
North America Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Human Rabies Immunoglobulin (IM) Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Human Rabies Immunoglobulin (IM) Consumption by Countries (2016-2021)
East Asia Human Rabies Immunoglobulin (IM) Consumption by Countries (2016-2021)
Europe Human Rabies Immunoglobulin (IM) Consumption by Region (2016-2021)
South Asia Human Rabies Immunoglobulin (IM) Consumption by Countries (2016-2021)
Southeast Asia Human Rabies Immunoglobulin (IM) Consumption by Countries (2016-2021)
Middle East Human Rabies Immunoglobulin (IM) Consumption by Countries (2016-2021)
Africa Human Rabies Immunoglobulin (IM) Consumption by Countries (2016-2021)
Oceania Human Rabies Immunoglobulin (IM) Consumption by Countries (2016-2021)
South America Human Rabies Immunoglobulin (IM) Consumption by Countries (2016-2021)
Rest of the World Human Rabies Immunoglobulin (IM) Consumption by Countries (2016-2021)
Global Human Rabies Immunoglobulin (IM) Sales Volume by Type (2016-2021)
Global Human Rabies Immunoglobulin (IM) Sales Volume Market Share by Type (2016-2021)
Global Human Rabies Immunoglobulin (IM) Sales Revenue by Type (2016-2021)
Global Human Rabies Immunoglobulin (IM) Sales Revenue Share by Type (2016-2021)
Global Human Rabies Immunoglobulin (IM) Sales Price by Type (2016-2021)
Global Human Rabies Immunoglobulin (IM) Consumption Volume by Application (2016-2021)
Global Human Rabies Immunoglobulin (IM) Consumption Volume Market Share by Application (2016-2021)
Global Human Rabies Immunoglobulin (IM) Consumption Value by Application (2016-2021)
Global Human Rabies Immunoglobulin (IM) Consumption Value Market Share by Application (2016-2021)
CSL Behring Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Grifols Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Sanofi Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
CNBG Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Kamada Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
CBPO Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Shuanglin Bio Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Weiguang Bio Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Shanghai RAAS Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Bharat Serum Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
VINS Human Rabies Immunoglobulin (IM) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Human Rabies Immunoglobulin (IM) Distributors List
Human Rabies Immunoglobulin (IM) Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Human Rabies Immunoglobulin (IM) Production Forecast by Region (2022-2027)
Global Human Rabies Immunoglobulin (IM) Sales Volume Forecast by Type (2022-2027)
Global Human Rabies Immunoglobulin (IM) Sales Volume Market Share Forecast by Type (2022-2027)
Global Human Rabies Immunoglobulin (IM) Sales Revenue Forecast by Type (2022-2027)
Global Human Rabies Immunoglobulin (IM) Sales Revenue Market Share Forecast by Type (2022-2027)
Global Human Rabies Immunoglobulin (IM) Sales Price Forecast by Type (2022-2027)
Global Human Rabies Immunoglobulin (IM) Consumption Volume Forecast by Application (2022-2027)
Global Human Rabies Immunoglobulin (IM) Consumption Value Forecast by Application (2022-2027)
North America Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
East Asia Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
Europe Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
South Asia Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
Southeast Asia Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
Middle East Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
Africa Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
Oceania Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
South America Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
Rest of the world Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources


Global Human Rabies Immunoglobulin (IM) Market Share by Type: 2021 VS 2027
ERIG Features
HRIG Features
Global Human Rabies Immunoglobulin (IM) Market Share by Application: 2021 VS 2027
Category II Exposure Case Studies
Category III Exposure Case Studies
Human Rabies Immunoglobulin (IM) Report Years Considered
Global Human Rabies Immunoglobulin (IM) Market Status and Outlook (2016-2027)
North America Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
East Asia Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
Europe Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
South Asia Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
South America Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
Middle East Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
Africa Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
Oceania Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
South America Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Human Rabies Immunoglobulin (IM) Revenue (Value) and Growth Rate (2016-2027)
North America Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
East Asia Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
Europe Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
South Asia Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
Southeast Asia Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
Middle East Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
Africa Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
Oceania Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
South America Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
Rest of the World Human Rabies Immunoglobulin (IM) Sales Volume Growth Rate (2016-2021)
North America Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
North America Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2021
United States Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Canada Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Mexico Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
East Asia Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
East Asia Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2021
China Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Japan Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
South Korea Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Europe Human Rabies Immunoglobulin (IM) Consumption and Growth Rate
Europe Human Rabies Immunoglobulin (IM) Consumption Market Share by Region in 2021
Germany Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
United Kingdom Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
France Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Italy Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Russia Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Spain Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Netherlands Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Switzerland Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Poland Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
South Asia Human Rabies Immunoglobulin (IM) Consumption and Growth Rate
South Asia Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2021
India Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Pakistan Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Bangladesh Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Southeast Asia Human Rabies Immunoglobulin (IM) Consumption and Growth Rate
Southeast Asia Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2021
Indonesia Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Thailand Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Singapore Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Malaysia Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Philippines Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Vietnam Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Myanmar Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Middle East Human Rabies Immunoglobulin (IM) Consumption and Growth Rate
Middle East Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2021
Turkey Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Saudi Arabia Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Iran Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
United Arab Emirates Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Israel Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Iraq Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Qatar Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Kuwait Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Oman Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Africa Human Rabies Immunoglobulin (IM) Consumption and Growth Rate
Africa Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2021
Nigeria Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
South Africa Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Egypt Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Algeria Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Morocco Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Oceania Human Rabies Immunoglobulin (IM) Consumption and Growth Rate
Oceania Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2021
Australia Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
New Zealand Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
South America Human Rabies Immunoglobulin (IM) Consumption and Growth Rate
South America Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2021
Brazil Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Argentina Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Columbia Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Chile Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Venezuelal Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Peru Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Puerto Rico Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Ecuador Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Rest of the World Human Rabies Immunoglobulin (IM) Consumption and Growth Rate
Rest of the World Human Rabies Immunoglobulin (IM) Consumption Market Share by Countries in 2021
Kazakhstan Human Rabies Immunoglobulin (IM) Consumption and Growth Rate (2016-2021)
Sales Market Share of Human Rabies Immunoglobulin (IM) by Type in 2021
Sales Revenue Market Share of Human Rabies Immunoglobulin (IM) by Type in 2021
Global Human Rabies Immunoglobulin (IM) Consumption Volume Market Share by Application in 2021
CSL Behring Human Rabies Immunoglobulin (IM) Product Specification
Grifols Human Rabies Immunoglobulin (IM) Product Specification
Sanofi Human Rabies Immunoglobulin (IM) Product Specification
Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Specification
CNBG Human Rabies Immunoglobulin (IM) Product Specification
Kamada Human Rabies Immunoglobulin (IM) Product Specification
CBPO Human Rabies Immunoglobulin (IM) Product Specification
Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Specification
Weiguang Bio Human Rabies Immunoglobulin (IM) Product Specification
Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Specification
Bharat Serum Human Rabies Immunoglobulin (IM) Product Specification
VINS Human Rabies Immunoglobulin (IM) Product Specification
Manufacturing Cost Structure of Human Rabies Immunoglobulin (IM)
Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Human Rabies Immunoglobulin (IM) Production Capacity Growth Rate Forecast (2022-2027)
Global Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
Global Human Rabies Immunoglobulin (IM) Price and Trend Forecast (2016-2027)
North America Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
North America Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
East Asia Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
East Asia Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
Europe Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
Europe Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
South Asia Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
South Asia Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
Southeast Asia Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
Middle East Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
Middle East Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
Africa Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
Africa Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
Oceania Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
Oceania Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
South America Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
South America Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
Rest of the World Human Rabies Immunoglobulin (IM) Production Growth Rate Forecast (2022-2027)
Rest of the World Human Rabies Immunoglobulin (IM) Revenue Growth Rate Forecast (2022-2027)
North America Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
East Asia Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
Europe Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
South Asia Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
Southeast Asia Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
Middle East Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
Africa Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
Oceania Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
South America Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
Rest of the world Human Rabies Immunoglobulin (IM) Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report

  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs